[go: up one dir, main page]

WO2013129970A3 - Pharmaceutical composition having vasoconstricting, anticongestant and anti-inflammatory activity (embodiments) - Google Patents

Pharmaceutical composition having vasoconstricting, anticongestant and anti-inflammatory activity (embodiments) Download PDF

Info

Publication number
WO2013129970A3
WO2013129970A3 PCT/RU2013/000135 RU2013000135W WO2013129970A3 WO 2013129970 A3 WO2013129970 A3 WO 2013129970A3 RU 2013000135 W RU2013000135 W RU 2013000135W WO 2013129970 A3 WO2013129970 A3 WO 2013129970A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
anticongestant
vasoconstricting
inflammatory activity
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/RU2013/000135
Other languages
French (fr)
Russian (ru)
Other versions
WO2013129970A2 (en
Inventor
Владимир Павлович ЛОБКО
Анастасия Геннадьевна ЧЕЛЯЕВА
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2013129970A2 publication Critical patent/WO2013129970A2/en
Publication of WO2013129970A3 publication Critical patent/WO2013129970A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to the field of the pharmaceutical industry and medicine and can be used for the production and application of pharmaceutical compositions having vasoconstricting, anticongestant and anti-inflammatory activity in cases of acute rhinitis, inflammatory processes of the maxillary sinuses, nosebleeds and conjunctivitis. The problem of the invention consists in producing a pharmaceutical composition on the basis of the preparation naphazoline by introducing mineral substances into the pharmaceutical composition, and substituting 12С carbon isotopes with 13С carbon isotopes in the pharmaceutical composition.
PCT/RU2013/000135 2012-02-29 2013-02-20 Pharmaceutical composition having vasoconstricting, anticongestant and anti-inflammatory activity (embodiments) Ceased WO2013129970A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EA201200211 2012-02-29
EA201200211A EA021295B1 (en) 2012-02-29 2012-02-29 Pharmaceutical composition having vasoconstricting, anticongestant, anti-inflammatory activity (embodiments)

Publications (2)

Publication Number Publication Date
WO2013129970A2 WO2013129970A2 (en) 2013-09-06
WO2013129970A3 true WO2013129970A3 (en) 2013-11-14

Family

ID=48916289

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2013/000135 Ceased WO2013129970A2 (en) 2012-02-29 2013-02-20 Pharmaceutical composition having vasoconstricting, anticongestant and anti-inflammatory activity (embodiments)

Country Status (2)

Country Link
EA (1) EA021295B1 (en)
WO (1) WO2013129970A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2156087C1 (en) * 1999-11-25 2000-09-20 Товарищество с ограниченной ответственностью Фирма "Электронная медицина" Biologically active addition
RU2251417C2 (en) * 2003-04-11 2005-05-10 Аникеев Сергей Владимирович Preparation for treating highmoritis named "antihighmoritis"
RU2281086C1 (en) * 2005-01-18 2006-08-10 Сергей Николаевич Анисимов Ophthalmic anti-histaminic drops
RU2412188C2 (en) * 2006-09-21 2011-02-20 Раквалиа Фарма Инк. Benzimidazole derivatives as selective acid pump inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3470131B2 (en) * 1994-03-16 2003-11-25 大正製薬株式会社 Long-acting nasal drops
US20050080043A1 (en) * 2000-09-20 2005-04-14 Lee Shahinian Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2156087C1 (en) * 1999-11-25 2000-09-20 Товарищество с ограниченной ответственностью Фирма "Электронная медицина" Biologically active addition
RU2251417C2 (en) * 2003-04-11 2005-05-10 Аникеев Сергей Владимирович Preparation for treating highmoritis named "antihighmoritis"
RU2281086C1 (en) * 2005-01-18 2006-08-10 Сергей Николаевич Анисимов Ophthalmic anti-histaminic drops
RU2412188C2 (en) * 2006-09-21 2011-02-20 Раквалиа Фарма Инк. Benzimidazole derivatives as selective acid pump inhibitors

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Registr lekarstvennykh sredstv Rossii.", RLS-APTEKAR. GI. RED. G.L. VYSHKOVSKY VYPUSK, vol. 5, 2003, pages 702 - 703 *
"Tekhnologia lekarstvennykh form.", POD RED. T.S. KONDRATEVOI, TOM 1, M., ''MEDITSINA, 1991, pages 364 *

Also Published As

Publication number Publication date
EA201200211A1 (en) 2013-07-30
EA021295B1 (en) 2015-05-29
WO2013129970A2 (en) 2013-09-06

Similar Documents

Publication Publication Date Title
TN2012000549A1 (en) Substituted 5-fluoro-1h-pyrazolopyridines and use thereof
HK1206779A1 (en) Modified polynucleotides for the production of nuclear proteins
GT201200250A (en) ARILTRIAZOLONAS LINKED TO BISARILO AND ITS USE
WO2012106407A3 (en) Diagnostic and therapeutic methods and products related to anxiety disorders
PH12013501143A1 (en) Substituted 1-benzylcycloalkylcarboxlic acids and use thereof
TN2016000022A1 (en) Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core
TN2013000529A1 (en) Trpm8 antagonists and their use in treatments
WO2011141685A3 (en) Systemic nasal compositions comprising cocoyl proline or at least one of the constituents thereof
SG11201600318RA (en) Novel indolizine derivatives, method for the production thereof and pharmaceutical compositions containing same
NZ702930A (en) Racecadotril liquid compositions
WO2014203275A3 (en) An improved process for the preparation of apixaban and intermediates thereof
EP4410369A3 (en) Composition for nasal application with improved stability
MX2015000179A (en) Itraconazole compositions and dosage forms, and methods of using the same.
EP2732028A4 (en) COMPOSITIONS AND METHODS FOR THE PRODUCTION OF ISOPRENE
IL237688A0 (en) Syringe containing a composition, especially a pharmaceutical composition, comprising immunoglobins, methods for the production thereof and use of same
TR201009167A2 (en) Pharmaceutical granules containing cephalosporin.
MX360047B (en) Solid unit with high fexofenadine content and process for the preparation thereof.
UY34743A (en) TYPICAL PHARMACEUTICAL COMPOSITION, PRODUCTION PROCESS OF THE TOPICAL PHARMACEUTICAL COMPOSITION, USE OF THE TYPICAL PHARMACEUTICAL COMPOSITION AND METHOD OF TOPIC TREATMENT OF PSORIASIS, Atopic DERMATITIS OR CHRONIC ECZEMAS
EP2871209A4 (en) BARIUM SULFATE COMPOSITE PARTICLES, RESIN COMPOSITION COMPRISING THE SAME, AND PROCESS FOR PRODUCING THE SAME
BR112014025972A8 (en) anamorelin monohydrochlorides, compositions, process for preparing anamorelin monohydrochloride, method for making a pharmaceutical dosage form and oral pharmaceutical dosage form
ATE481393T1 (en) NEW CYCLOALKYL-BENZOTHIADIAZINE DERIVATIVES, THEIR PRODUCTION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP2983684B8 (en) Essential oil and aloe for treatment and prophylaxis of inflammations caused by demodex, especially marginal blepharitis, a pharmaceutical composition containing essential oil and/or aloe and the use of essential oil and aloe and their compositions for the production of a preparation used in treatment and prophylaxis of the mentioned inflammations
BR112014011745A2 (en) pharmaceutical composition and process for the manufacture of a hydrocortisone pharmaceutical composition
BR112013015501A2 (en) compound, pharmaceutical composition, methods for treating viral infections and inflammatory disorders, and the process for producing a miasynthetic sangliferrin
WO2013129970A3 (en) Pharmaceutical composition having vasoconstricting, anticongestant and anti-inflammatory activity (embodiments)

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 13755365

Country of ref document: EP

Kind code of ref document: A2